CV2 COST-EFFECTIVENESS OF ROSUVASTATIN VERSUS ATORVASTATIN, SIMVASTATIN, AND PRAVASTATIN FROM A CANADIAN HEALTH CARE PERSPECTIVE
Nov 1, 2007, 00:00
10.1016/S1098-3015(10)64855-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)64855-3/fulltext
Title :
CV2 COST-EFFECTIVENESS OF ROSUVASTATIN VERSUS ATORVASTATIN, SIMVASTATIN, AND PRAVASTATIN FROM A CANADIAN HEALTH CARE PERSPECTIVE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64855-3&doi=10.1016/S1098-3015(10)64855-3
First page :
Section Title :
Open access? :
No
Section Order :
13